Rural hospitals are isolated without adequate funding needed to provide for clinical services offered at larger health systems. The purpose of this study is to determine the clinical pharmacy services available and desired by rural hospitals in North Carolina.
Methods:
This prospective, cross-sectional, survey was distributed to a cohort of rural pharmacy directors and managers at rural hospitals across North Carolina. Data collected pertained to characteristics of the hospital and pharmacy, pharmacy director, clinical services, and responder impressions on their ability to maintain or enhance clinical services. Responses were summarized utilizing descriptive statistics and free-responses were coded for similar themes.
Results:
Seventeen respondents (32.6%) completed the survey. Clinical activities varied, as did characteristics of the hospitals and staff. Improved patient care is the primary reason why hospital pharmacies expand their clinical participation (46.7%). Pharmacy directors believed growth of clinical activities was a long-term goal while reporting regulations, staff, and finances as barriers to growth.
Conclusion:
Clinical pharmacy services vary in NC rural hospitals. Directors exhibit a willingness to expand clinical responsibilities. Rural hospital pharmacy directors desire pharmacists to be active clinically in patient care, but face barriers in reaching that goal.
BondCARaehlCL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26(6):735–747.
3.
BondCARaehlCL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy. 2004;24(8):953–963.
4.
LeeAJBoroMSKnappKK, et al.Clinical and economic outcomes of pharmacist recommendations in a veterans affairs medical center. Am J Health Syst Pharm. 2002;59(21):2070–2077.
5.
KrupickaMIBrattonSLSonnenthalK, et al.Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med. 2002;30(4):919–921.
6.
LeapeLLCullenDJClappMD, et al.Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–270.
7.
BoykoWLYurkowskiPJIveyMF, et al.Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;54(14):1591–1595.
8.
ChevalierBAWatsonBMBarrasMA, et al.Hospital pharmacists’ perceptions of medication counseling: a focus group study. Res Social Adm Pharm. 2016;12(5):756–771.
9.
LuetschK. Attitudes and attributes of pharmacists in relation to practice change – a scoping review and discussion. Res Social Adm Pharm. 2017;13(3):440–455.e411.
10.
UllrichFMuellerKJ; Centers RHRP, RUPRI Center for Rural Health Policy Analysis University of Iowa College of Public Health, Department of Health Management and Policy. Update: independently owned pharmacy closures in rural America, 2003-2013. Rural Policy Brief. 2014;(2014 7):1–4.
11.
OladeRA. Evidence-based practice and research utilization activities among rural nurses. J Nurs Scholarsh. 2004;36(3):220–225.
12.
KaufmanBGThomasSRRandolphRK, et al.The rising rate of rural hospital closures. J Rural Health. 2016;32(1):35–43.
13.
HolmesM. Financially fragile rural hospitals: mergers and closures. N C Med J. 2015;76(1):37–40.
14.
HolmesGMKaufmanBGPinkGH. Predicting financial distress and closure in rural hospitals. J Rural Health. 2017;33(3):239–249.
15.
LindroothRCPerraillonMCHardyRY, et al.Understanding the relationship between Medicaid expansions and hospital closures. Health Aff (Millwood). 2018;37(1):111–120.
16.
HolmesGMSlifkinRTRandolphRK, et al.The effect of rural hospital closures on community economic health. Health Serv Res. 2006;41(2):467–485.
17.
HaleJCMurawskiMMIvesTJ. Practice characteristics and geographic distribution of clinical pharmacist practitioner in North Carolina. NC Med J. 2015;76(4):205–210.
MurawskiMVillaKRDoleEJ, et al.Advanced-practice pharmacists: practice characteristics and reimbursement of pharmacists certified for collaborative clinical practice in New Mexico and North Carolina. Am J Health Syst Pharm. 2011;68(24):2341–2350.
North Carolina Administrative Code: Board of Pharmacy – Pharmacy Rules: North Carolina Board of Pharmacy. 2017. Accessed September 14, 2017. http://www.ncbop.org/lawsrules/rules.pdf.
Pharmacists ASoH. ASHP guidelines: minimum standard for pharmacies in hospitals. Am J Health Syst Pharm. 2013;70(18):1619–1630.
25.
RaehlCLBondCAPitterleME. Hospital pharmacy services in the Great Lakes region. Am J Hosp Pharm. 1990;47(6):1283–1303.
26.
FernandesOGormanSKSlavikRS, et al.Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach. Ann Pharmacother. 2015;49(6):656–669.
27.
KaboliPJHothABMcClimonBJ, et al.Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–964.
28.
BlixHSViktilKKMogerTA, et al.Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28(3):152–158.
29.
KimMMBarnatoAEAngusDC, et al.The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med. 2010;170(4):369–376.
30.
NajafzadehMSchnipperJLShrankWH, et al.Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge. Am J Manag Care. 2016;22(10):654–661.
31.
SmithSBMangoMD. Pharmacy-based medication reconciliation program utilizing pharmacists and technicians: a process improvement initiative. Hosp Pharm. 2013;48(2):112–119.
32.
JobinJIrwinANPimentelJ, et al.Accuracy of medication histories collected by pharmacy technicians during hospital admission. Res Social Adm Pharm.2018;14(7):695–699. Epub 2017.
33.
MishraPThomasJ. Survey of collaborative drug therapy management in U.S. hospitals. Am J Health Syst Pharm. 2017;74(21):1791–1905.
34.
PedersenCASchneiderPJ, et al.ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education-2015. Am J Health Syst Pharm. 2016;73(17):1307–1330.
35.
HiranoRSakamotoYKitazawaJ, et al.Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant. Infect Drug Resist. 2016;9:243–252.
36.
StoesselAMHaleCMSeaburyRW, et al.The impact of AUC-based monitoring on pharmacist-directed vancomycin dose adjustments in complicated methicillin-resistant staphylococcus aureus infection. J Pharm Pract. 2018. doi: 10.1177/0897190018764564.
37.
StreetmanDSNafzigerANDestacheCJ, et al.Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs. Pharmacotherapy. 2001;21(4):443–451.
38.
PedersenCASchneiderPJScheckelhoffDJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2013. Am J Health Syst Pharm. 2014;71(11):924–942.
39.
BondCARaehlCLFrankeT. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001;21(2):129–141.
40.
BeardJAshleyMChalkleyD. Improving the efficiency of a hospital pharmacy service: the journey of one hospital pharmacy. Eur J Hospital Pharm. 2014;21(4):208–215.
41.
O’BrienJM. How nurse practitioners obtained provider status: lessons for pharmacists. Am J Health Syst Pharm. 2003;60(22):2301–2307.
42.
GallagherJMcCarthySByrneS. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36(6):1101–1114.
43.
De RijdtTWillemsLSimoensS. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65(12):1161–1172.
44.
MinardLVDealHHarrisonME, et al.Pharmacists’ perceptions of the barriers and facilitators to the implementation of clinical pharmacy key performance indicators. PLoS One. 2016;11(4):e0152903.
45.
HardiganPCPopoviciICarvajalMJ. Response rate, response time, and economic costs of survey research: a randomized trial of practicing pharmacists. Res Social Adm Pharm. 2016;12(1):141–148.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
